Výsledky vyhledávání

Concomitant use of benzodiazepines in chronic pain patients adherent to extended-release tapentadol or oxycodone treatment—A retrospective claims analysis

Autor: D Vukicevic, Martina Imro, V. Zah, Steven D. Passik, Michael DeGeorge, S Tatovic

Publikováno v: Journal of Opioid Management. 16:461-479

Objective: To compare concomitant benzodiazepine (BZDs) use among chronic pain patients adherent to extended-release tapentadol (TapER) or oxycodone (OxnER) and estimate the number of lives potentially saved by switching patients to the less BZD copr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34ff4f38af2bbe4cd99e9a191dc5e141
https://doi.org/10.5055/jom.2020.0604

Zobrazit plný text záznamu

Healthcare Costs and Resource Use of Patients with Dupuytren Contracture Treated with Collagenase Clostridium Histolyticum or Fasciectomy: A Propensity Matching Analysis

Autor: Martina Imro, V. Zah, David Hurley, J. Ruby, J Pelivanovic, D Vukicevic, S Tatovic

Publikováno v: ClinicoEconomics and Outcomes Research: CEOR

Vladimir Zah,1 Jovana Pelivanovic,1 Simona Tatovic,1 Djurdja Vukicevic,1 Martina Imro,1 Jane Ruby,2 David Hurley2 1Health Economics and Outcomes Research Department, ZRx Outcomes Research Inc., Mississauga, ON, Canada; 2Medical Affairs, Endo Pharmace

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2ac5820c0ee1a8b12e011c2a6d9ddc8
https://doi.org/10.2147/ceor.s269957

Zobrazit plný text záznamu

The burden of productivity loss of U.S. commercially insured patients diagnosed with Dupuytren’s disease undergoing collagenase versus fasciectomy treatment

Autor: V. Zah, Martina Imro, D Vukicevic, David Hurley, S Tatovic

Publikováno v: Expert Review of Pharmacoeconomics & Outcomes Research. 21:127-136

Background: We conducted a comparative assessment of the productivity loss associated with the two different treatment options for Dupuytren’s disease: collagenase and fasciectomy. Methods: The retrospective claims analysis was performed using the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57831619c45f5684e33246f71004a8d5
https://doi.org/10.1080/14737167.2020.1770085

Zobrazit plný text záznamu

Healthcare Costs And Resource Utilization In Chronic Pain Patients Treated With Extended-Release Formulations Of Tapentadol, Oxycodone, Or Morphine Stratified By Type Of Pain: A Retrospective Claims Analysis, 2012-2016

Autor: D Vukicevic, S Tatovic, J Pelivanovic, V. Zah, Martina Imro, Rowe B Brookﬁeld

Publikováno v: Journal of Pain Research

Vladimir Zah,1 Rowe B Brookï¬eld,2 Martina Imro,1 Simona Tatovic,1 Jovana Pelivanovic,1 Djurdja Vukicevic1 1Health Economics and Outcomes Research Department, ZRx Outcomes Research Inc, Mississauga, Ontario, Canada; 2Field Medical Affairs, Depome

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a68b3858e56c20fe32b43b7b702435e
https://pubmed.ncbi.nlm.nih.gov/31819597

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání